Effecting C-O activation of oxazolidinones by Ni to construct small, chiral heter
Effecting C-O activation of oxazolidinones by Ni to construct small, chiral heter
批准号:
8588792
负责人:
Matthew Steven Winston
金额:
$5.15万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-11-16 至 2015-11-15
关键词:
AlkenesAmino AlcoholsAziridinesBiological FactorsCarbon DioxideCarbon MonoxideCatalysisComplexDecarboxylationDevelopmentElectron Spin Resonance SpectroscopyEvaluationExhibitsIndustryLactamsLibrariesLigandsMagnetic ResonanceMediatingMethodsModelingNickelNitrogenNuclearOxazolidinonesPathway interactionsPharmacologic SubstancePhasePropertyPyrrolidinesReactionSolventsTherapeuticTransition ElementsWorkantineoplastic antibioticscarbenecatalystcombinatorialdiscountdrug discoveryinsightlarge scale productionmolecular recognitionnovelpharmacophoreplanetary Atmospherepublic health relevancepyrrolidinepyrrolineresearch studyscreeningsynthetic drug
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Given their wide availability, chiral oxazolidinones are potentially useful but ignored substrates for catalysis. Using transition metal catalysts, CO2 extrusion from oxazolidinones could be envisioned to afford reactive aza-metallacyclobutane intermediates that can be taken to a variety of complex nitrogenous products. The Ni-catalyzed transformation of chiral oxazolidinones to small chiral heterocycles, such as aziridines and ¿-lactams, will be developed. Following Ni-mediated alkyl C-O insertion into a chiral oxazolidinone, decarboxylation will afford the aza-metallacyclobutane intermediate. Reductive elimination will afford chiral aziridines. Alternatively, under a carbon monoxide atmosphere, highly substituted chiral ¿-lactams can be constructed. Many natural products containing chiral aziridine or ¿-lactam functionality exhibit medicinally important properties, such as anticancer and antibiotic activity; however, due to the scarcity of methods toward the synthesis of these chiral heterocycles, they present formidable synthetic challenges. The Ni-catalyzed method outlined in this proposal would offer a convenient, facile, and divergent approach to these pharmacophores from readily available chiral precursors. Importantly, this method can be used combinatorially to construct libraries of potentially bioactive molecules. Reaction screening will be carried out on a simple, unsubstituted oxazolidinone model substrate to optimize reaction conditions, including ligands and solvent. Substrates of higher-substitution will then be evaluated in this transformation. Mechanistic and spectroscopic studies, including radical trap experiments, are proposed to determine whether a Ni0/NiII or NiI/NiIII cycle operates, and whether deleterious loss of stereochemical information occurs via a radical intermediate. In addition, hypothesized intermediates will be synthesized and subjected to reaction conditions to determine whether or not they lie along the catalytic cycle. By gaining insight into the mechanism of the proposed transformation, further optimization can be rationalized, and the method made general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effecting C-O activation of oxazolidinones by Ni to construct small, chiral heter
-
批准号:8398979
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2012
-
负责人:Matthew Steven Winston
-
依托单位:
海外基金